Pharmaceutical composition comprising antibody composition which specifically binds to CCR4

Patent Number: 9387248

Patent Date: 2016-07-12

Patent type: utility

A pharmaceutical composition, comprising an antibody composition which specifically binds to human CC chemokine receptor 4 (hereinafter also referred to as CCR4) and at least one medicament; and a pharmaceutical composition for administering in combination of a recombinant antibody against CCR4 and at least one medicament are required. The present invention can provide a pharmaceutical composition comprising a recombinant antibody against CCR4 and at least one medicament; and a pharmaceutical composition for administering in combination of a recombinant antibody against CCR4 and at least one medicament.

Inventors

First Name Last Name City State Country
Toshihiko Ishii - - -
Miyoko Asano - - -

IPCs

Section Class Sub Class Group Sub Group
A 61 K 39 395
A 61 K 31 454
A 61 K 45 06

Assignee

Organization First Name Last Name City State Country
Kyowa Hakko Kirin Co., Ltd. - - - - -